Strategies for H-score Normalization of Preanalytical Technical Variables with Potential Utility to Immunohistochemical-Based Biomarker Quantitation in Therapeutic Reponse Diagnostics
Digital quantitative immunohistochemical analysis of protein biomarker expression offers a broad dynamic range against which clinical outcomes may be measured. Semi-quantitative expression data represented as an H-score is produced by computer generated average intensity of positive staining given w...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Analytical Cellular Pathology |
Online Access: | http://dx.doi.org/10.3233/ACP-2011-014 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832558956216582144 |
---|---|
author | William E. Pierceall Michele Wolfe Jessica Suschak Hua Chang Yan Chen Kam M. Sprott Jeffery L. Kutok Stella Quan David T. Weaver Brian E. Ward |
author_facet | William E. Pierceall Michele Wolfe Jessica Suschak Hua Chang Yan Chen Kam M. Sprott Jeffery L. Kutok Stella Quan David T. Weaver Brian E. Ward |
author_sort | William E. Pierceall |
collection | DOAJ |
description | Digital quantitative immunohistochemical analysis of protein biomarker expression offers a broad dynamic range against which clinical outcomes may be measured. Semi-quantitative expression data represented as an H-score is produced by computer generated average intensity of positive staining given weight by the percentage of cells showing positive staining. While patient H-scores vary for biological reasons, variation may also arise from preanalytic technical issues, such as differences in fixation protocols. In this study, we present data on two candidate calibrator nuclear-localized proteins, SNRPA and SnRNP70, with robust and consistent expression levels across breast cancers. Quantitative expression measurement of these two candidate biomarkers may potentially be used to eliminate the effect of differences in preanalytic processing of specimens by normalizing H-scores derived from test biomarkers of interest. To examine the effects of preanalytical fixation variation on biomarker quantitation and potential utility of candidate calibrators to address such issues, 6 surgically-resected human breast cancer patient specimens were divided into 6 portions and fixed under distinct conditions (fixation following resection in formalin for 2 hr, 8 hr or 48 hr, or held overnight at 4°C in buffered saline prior to formalin fixation for 2 hr, 8 hr, or 48 hr). We find H-score variation between fixation conditions within individual patient's tumors that were stained for XPF, ATM, BRCA1, pMK2 and PARP1. Most interestingly, detectable expression of SNRPA and SnRNP70 is covariant to test biomarkers under distinct fixation conditions and so these hold the potential for serving as calibration standards for general antigen preservation and reactivity. |
format | Article |
id | doaj-art-c3d2f9acca124062a912c1cd75184915 |
institution | Kabale University |
issn | 2210-7177 2210-7185 |
language | English |
publishDate | 2011-01-01 |
publisher | Wiley |
record_format | Article |
series | Analytical Cellular Pathology |
spelling | doaj-art-c3d2f9acca124062a912c1cd751849152025-02-03T01:31:17ZengWileyAnalytical Cellular Pathology2210-71772210-71852011-01-0134315916810.3233/ACP-2011-014Strategies for H-score Normalization of Preanalytical Technical Variables with Potential Utility to Immunohistochemical-Based Biomarker Quantitation in Therapeutic Reponse DiagnosticsWilliam E. Pierceall0Michele Wolfe1Jessica Suschak2Hua Chang3Yan Chen4Kam M. Sprott5Jeffery L. Kutok6Stella Quan7David T. Weaver8Brian E. Ward9Applied Molecular Diagnostic Group, On-Q-ity, Inc., Waltham, MA, USAApplied Molecular Diagnostic Group, On-Q-ity, Inc., Waltham, MA, USAApplied Molecular Diagnostic Group, On-Q-ity, Inc., Waltham, MA, USAApplied Molecular Diagnostic Group, On-Q-ity, Inc., Waltham, MA, USAApplied Molecular Diagnostic Group, On-Q-ity, Inc., Waltham, MA, USAApplied Molecular Diagnostic Group, On-Q-ity, Inc., Waltham, MA, USADepartment of Pathology, Brigham and Womens' Hospital, Boston, MA, USAApplied Molecular Diagnostic Group, On-Q-ity, Inc., Waltham, MA, USAApplied Molecular Diagnostic Group, On-Q-ity, Inc., Waltham, MA, USAApplied Molecular Diagnostic Group, On-Q-ity, Inc., Waltham, MA, USADigital quantitative immunohistochemical analysis of protein biomarker expression offers a broad dynamic range against which clinical outcomes may be measured. Semi-quantitative expression data represented as an H-score is produced by computer generated average intensity of positive staining given weight by the percentage of cells showing positive staining. While patient H-scores vary for biological reasons, variation may also arise from preanalytic technical issues, such as differences in fixation protocols. In this study, we present data on two candidate calibrator nuclear-localized proteins, SNRPA and SnRNP70, with robust and consistent expression levels across breast cancers. Quantitative expression measurement of these two candidate biomarkers may potentially be used to eliminate the effect of differences in preanalytic processing of specimens by normalizing H-scores derived from test biomarkers of interest. To examine the effects of preanalytical fixation variation on biomarker quantitation and potential utility of candidate calibrators to address such issues, 6 surgically-resected human breast cancer patient specimens were divided into 6 portions and fixed under distinct conditions (fixation following resection in formalin for 2 hr, 8 hr or 48 hr, or held overnight at 4°C in buffered saline prior to formalin fixation for 2 hr, 8 hr, or 48 hr). We find H-score variation between fixation conditions within individual patient's tumors that were stained for XPF, ATM, BRCA1, pMK2 and PARP1. Most interestingly, detectable expression of SNRPA and SnRNP70 is covariant to test biomarkers under distinct fixation conditions and so these hold the potential for serving as calibration standards for general antigen preservation and reactivity.http://dx.doi.org/10.3233/ACP-2011-014 |
spellingShingle | William E. Pierceall Michele Wolfe Jessica Suschak Hua Chang Yan Chen Kam M. Sprott Jeffery L. Kutok Stella Quan David T. Weaver Brian E. Ward Strategies for H-score Normalization of Preanalytical Technical Variables with Potential Utility to Immunohistochemical-Based Biomarker Quantitation in Therapeutic Reponse Diagnostics Analytical Cellular Pathology |
title | Strategies for H-score Normalization of Preanalytical Technical Variables with Potential Utility to Immunohistochemical-Based Biomarker Quantitation in Therapeutic Reponse Diagnostics |
title_full | Strategies for H-score Normalization of Preanalytical Technical Variables with Potential Utility to Immunohistochemical-Based Biomarker Quantitation in Therapeutic Reponse Diagnostics |
title_fullStr | Strategies for H-score Normalization of Preanalytical Technical Variables with Potential Utility to Immunohistochemical-Based Biomarker Quantitation in Therapeutic Reponse Diagnostics |
title_full_unstemmed | Strategies for H-score Normalization of Preanalytical Technical Variables with Potential Utility to Immunohistochemical-Based Biomarker Quantitation in Therapeutic Reponse Diagnostics |
title_short | Strategies for H-score Normalization of Preanalytical Technical Variables with Potential Utility to Immunohistochemical-Based Biomarker Quantitation in Therapeutic Reponse Diagnostics |
title_sort | strategies for h score normalization of preanalytical technical variables with potential utility to immunohistochemical based biomarker quantitation in therapeutic reponse diagnostics |
url | http://dx.doi.org/10.3233/ACP-2011-014 |
work_keys_str_mv | AT williamepierceall strategiesforhscorenormalizationofpreanalyticaltechnicalvariableswithpotentialutilitytoimmunohistochemicalbasedbiomarkerquantitationintherapeuticreponsediagnostics AT michelewolfe strategiesforhscorenormalizationofpreanalyticaltechnicalvariableswithpotentialutilitytoimmunohistochemicalbasedbiomarkerquantitationintherapeuticreponsediagnostics AT jessicasuschak strategiesforhscorenormalizationofpreanalyticaltechnicalvariableswithpotentialutilitytoimmunohistochemicalbasedbiomarkerquantitationintherapeuticreponsediagnostics AT huachang strategiesforhscorenormalizationofpreanalyticaltechnicalvariableswithpotentialutilitytoimmunohistochemicalbasedbiomarkerquantitationintherapeuticreponsediagnostics AT yanchen strategiesforhscorenormalizationofpreanalyticaltechnicalvariableswithpotentialutilitytoimmunohistochemicalbasedbiomarkerquantitationintherapeuticreponsediagnostics AT kammsprott strategiesforhscorenormalizationofpreanalyticaltechnicalvariableswithpotentialutilitytoimmunohistochemicalbasedbiomarkerquantitationintherapeuticreponsediagnostics AT jefferylkutok strategiesforhscorenormalizationofpreanalyticaltechnicalvariableswithpotentialutilitytoimmunohistochemicalbasedbiomarkerquantitationintherapeuticreponsediagnostics AT stellaquan strategiesforhscorenormalizationofpreanalyticaltechnicalvariableswithpotentialutilitytoimmunohistochemicalbasedbiomarkerquantitationintherapeuticreponsediagnostics AT davidtweaver strategiesforhscorenormalizationofpreanalyticaltechnicalvariableswithpotentialutilitytoimmunohistochemicalbasedbiomarkerquantitationintherapeuticreponsediagnostics AT brianeward strategiesforhscorenormalizationofpreanalyticaltechnicalvariableswithpotentialutilitytoimmunohistochemicalbasedbiomarkerquantitationintherapeuticreponsediagnostics |